Deliver Your News to the World

Agilent Technologies and Integrated DNA Technologies Sign Co-Marketing Agreement for qPCR Studies


SANTA CLARA, Calif. and CORALVILLE, Iowa, Agilent Technologies Inc. (NYSE: A) and Integrated DNA Technologies (IDT) have partnered to provide a complete solution for qPCR studies. The combination of the Mx3005P qPCR system and Brilliant qPCR reagents from Agilent with PrimeTime qPCR Assays from IDT provides customers a fully supported solution that is ideal for qPCR studies.

“The partnership provides the benefit of performing 5’ nuclease probe assays with qPCR reagents that have been extensively tested against competitor reagents and assays,” said Scott O’Brien, product line manager in Agilent’s genomics division. “Customers will benefit from better technical support from the validation of the Mx system, Brilliant reagents and PrimeTime qPCR Assays together.”

Coupling PrimeTime qPCR Assays with the Brilliant master mix allows researchers to easily expand the scope of their research studies. The combination will provide an excellent tool for validating discoveries resulting from next-generation sequencing (NGS) and copy number variation (CNV) studies. PrimeTime allows for greater flexibility in assay design due to the variety of options available, including choices of scales, dye/quencher combinations and primer-to-probe ratios. The PrimeTime qPCR Assays are available in three scales, including the PrimeTime Mini, which provides a reduced cost-per-assay and allows researchers to study more assays across a fewer numbers of samples.

Agilent’s Brilliant II and Brilliant III Ultra-Fast qPCR and qRT-PCR Master Mix kits offer superior sensitivity for improved accuracy and reproducibility of nucleic acid quantification. The combined product set provides the complete solution for gene expression studies and a wide array of growing qPCR applications at affordable prices.

“Agilent’s gene expression product line matches well with IDT’s qPCR assays,” said Stephen Gunstream, vice president of marketing and strategy at IDT. “We believe this combination will provide superior results for gene expression researchers.”

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the world, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT’s primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit
About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $4.5 billion in fiscal 2009. Information about Agilent is available on the Web at


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.